abstract |
The present invention relates to compositions and methods for treating cancer. More specifically, the present invention provides a subject with cancer that specifically lyses tumor cells and actively targets tumor cells and cell debris to antigen-presenting cells to provide anti-tumor immunity. Relates to engineered oncolytic virus compositions for the administration of [Selection] Figure 1 |